Public stakeholder meeting: approval, safety monitoring and impact of COVID-19 vaccines in the EU
Event
Human
COVID-19
Date
Location
This third public meeting updated EU citizens about the continued assessment, approval and safety monitoring of COVID-19 vaccines, and their expected impact at community level.
It covered:
The event also allowed the public and stakeholders to further inform EMA of their needs, expectations and any concerns.
Full video recording
Update on approved and candidate COVID-19 vaccines in the EU, Marco Cavaleri (EMA)
Vaccines safety monitoring – update on emerging data since EU authorisations, Peter Arlett (EMA)
Expected impact of COVID-19 vaccination in the European Union, Edoardo Colzani (ECDC)
Transparency and publication of clinical data for COVID-19 vaccines, Melanie Carr (EMA)